Skip to Content
Merck
CN
  • Decidualization induces a secretome switch in perivascular niche cells of the human endometrium.

Decidualization induces a secretome switch in perivascular niche cells of the human endometrium.

Endocrinology (2014-08-15)
Keisuke Murakami, Yie Hou Lee, Emma S Lucas, Yi-Wah Chan, Ruban Peter Durairaj, Satoru Takeda, Jonathan D Moore, Bee K Tan, Siobhan Quenby, Jerry K Y Chan, Caroline E Gargett, Jan J Brosens
ABSTRACT

The endometrial perivascular microenvironment is rich in mesenchymal stem-like cells that express type 1 integral membrane protein Sushi domain containing 2 (SUSD2) but the role of these cells in the decidual transformation of this tissue in pregnancy is unknown. We used an antibody directed against SUSD2 (W5C5) to isolate perivascular (W5C5(+)) and nonperivascular (W5C5(-)) fibroblasts from mid-luteal biopsies. We show that SUSD2 expression, and hence the ratio of W5C5(+):W5C5(-) cells, changes in culture depending on cell-cell contact and activation of the Notch signaling pathway. RNA sequencing revealed that cultures derived from W5C5(+) progenitor cells remain phenotypically distinct by the enrichment of novel and established endometrial perivascular signature genes. In an undifferentiated state, W5C5(+)-derived cells produced lower levels of various chemokines and inflammatory modulators when compared with their W5C5(-) counterparts. This divergence in secretomes was switched and became more pronounced upon decidualization, which transformed perivascular W5C5(+) cells into the dominant source of a range of chemokines and cytokines, including leukemia inhibitory factor and chemokine (C-C motif) ligand 7. Our findings suggest that the decidual response is spatially organized at the embryo-maternal interface with differentiating perivascular cells establishing distinct cytokine and chemokine profiles that could potentially direct trophoblast toward maternal vessels and govern local immune responses in pregnancy.

MATERIALS
Product Number
Brand
Product Description

Medroxyprogesterone acetate, European Pharmacopoeia (EP) Reference Standard
USP
Medroxyprogesterone acetate, United States Pharmacopeia (USP) Reference Standard
Supelco
Medroxyprogesterone 17-acetate, VETRANAL®, analytical standard
Sigma-Aldrich
DAPT, ≥98% (HPLC), solid
SAFC
L-Glutamine
Medroxyprogesterone acetate for system suitability, European Pharmacopoeia (EP) Reference Standard
Supelco
L-Glutamine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Glutamine, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
L-Glutamine, γ-irradiated, BioXtra, suitable for cell culture
Supelco
L-Glutamine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
L-Glutamine, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
L-Glutamine
Sigma-Aldrich
L-Glutamine, meets USP testing specifications, suitable for cell culture, 99.0-101.0%, from non-animal source
Sigma-Aldrich
L-Glutamine, Vetec, reagent grade, ≥99%
Medroxyprogesterone acetate for peak identification, European Pharmacopoeia (EP) Reference Standard